| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
2,363.35
|
|
Change (%)
|
-12.65 (-0.53%)
|
|
Best Buy (RS)
|
2362.2(x14)
|
|
Best Sell (RS)
|
2363.35(x2)
|
|
Today's Range (RS)
|
2,358.95
-
2,416.15
|
|
52-Week Range (RS)
|
1,838.65
-
2,530.00
|
|
Beta (1 Year)
|
0.54
|
|
|
|
|
|
| Index Details |
| BSE 100, BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Shariah 50 |
| News |
|
Corporate Details |
| Lupin launches Sugammadex Injection in U.S. market |
| Lupin receives USFDA approval for Diazepam Injection USP |
| Lupin to table results |
| Lupin grants exclusive rights to Kaveri Therapeutics Inc. for advancing two oncology programs |
| Lupin to convene AGM |
| Lupin allots 2,358 equity shares under ESOP |
| Lupin fixes record date for final dividend |
| Lupin receives EMA approval for Pediatric Indication of NaMuscla |
| Lupin gains as receives USFDA tentative nod for generic Xtandi tablets |
| Lupin receives USFDA tentative approval for Enzalutamide Tablets |
|
|
|
| Incoporation Year : 1983 |
| Chairman : M D Gupta |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Lupin Ltd
Kalpataru Inspire 3rd Floor,
Off Western Exp HW Santacruz-E,
Mumbai,
Maharashtra-400055 |
Phone:91-22-6640 2323
Fax:91-22-6640 8131 |
| E-Mail : investorservices@lupinpharma.com |
URL : https://www.lupin.com
|
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
28-Jul-2026 |
2394.70 |
-0.78 |
| 1Month |
06-Jul-2026 |
2492.45 |
-4.67 |
| 3Month |
04-May-2026 |
2350.95 |
1.07 |
| 6Month |
04-Feb-2026 |
2194.60 |
8.27 |
| 1Year |
04-Aug-2025 |
1883.00 |
26.18 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| HDFC Balanced Advantage Fund |
1.29 |
1375.55 |
| HDFC Large Cap Fund |
2.86 |
1116.61 |
| Mirae Asset Large & Midcap Fund |
2.03 |
892.40 |
| HDFC Flexi Cap Fund |
0.84 |
891.95 |
| Nippon India Pharma Fund |
7.45 |
673.45 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Sun Pharmaceutical Industries Ltd |
1,939.90 |
-1.03 |
2,047.55 |
1,547.25 |
470,269.65 |
| Cipla Ltd |
1,445.45 |
-0.31 |
1,672.20 |
1,165.55 |
117,137.57 |
| Zydus Lifesciences Ltd |
1,106.50 |
-1.07 |
1,181.00 |
835.85 |
111,570.80 |
| Mankind Pharma Ltd |
2,444.25 |
-0.68 |
2,670.00 |
1,909.90 |
101,638.31 |
| Laurus Labs Ltd |
1,849.45 |
0.76 |
1,840.45 |
810.75 |
99,174.31 |
|
|
|
|